Ann: FDA Fast Track Designation Granted for VAXINIA Trial Program, page-399

I must say that when I heard how CF33 was discovered (filling a flask with a range of known viruses, watching them replicate/mutate and then testing everything new that appeared) it struck me as troubling because it sounds like a process that could be easily replicated by other research labs.

The fact that this process came up with not just one but at least two universal cancer killing viruses suggests that perhaps this wasn't a one in a million lucky occurrence.

If CF33 is successful, big pharma have the choice of paying tens of billions of dollars to license it, or they could use the same process to find another similar virus that works just as well. Presumably there's a reasonable chance that they are already in the process of doing exactly that.

We may have a first mover advantage but we could potentially be competing in a crowded market a few years down the line.